The Geanetic Counsellor's Answer to Dline's Question

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

marty decided that it was time to find out his gean status, but he wanted to have some control over the process. The one thing he knew he didn't want to be anywhere he needed to visit again when he got the call. He is now in the open label trial and taking guntonerimup. It's another antibody which clears plac but so far has shown no clinical benefits for marti.

Marty Reiswig is fit and healthy, but every two weeks he is injected with the experimental drug gantenerumab and has monthly MRI scans. He submits to this because a rare genetic mutation runs in his family that predisposes them to early-onset Alzheimer’s disease.

We spoke to him about his experience on the trial, and why he chose to continue trialling the drug even after formal clinical trials were discontinued.

Produced and narrated by Lorna Stewart.

More on this story:

News Feature: Could drugs prevent Alzheimer’s? These trials aim to find out

Resources for those affected by Alzheimer's:

Alzheimer's association

Alzheimers.gov

Alzheimer's society

Hosted on Acast. See acast.com/privacy for more information.